Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.51 - $17.1 $208,184 - $6.98 Million
-408,205 Reduced 79.99%
102,121 $72,000
Q3 2022

Nov 14, 2022

BUY
$1.01 - $17.0 $320,724 - $5.4 Million
317,549 Added 164.72%
510,326 $776,000
Q2 2022

Aug 15, 2022

BUY
$0.54 - $1.41 $45,872 - $119,778
84,949 Added 78.78%
192,777 $191,000
Q1 2022

May 16, 2022

SELL
$1.4 - $5.15 $103,125 - $379,354
-73,661 Reduced 40.59%
107,828 $155,000
Q4 2021

Feb 14, 2022

BUY
$4.27 - $6.97 $105,486 - $172,186
24,704 Added 15.76%
181,489 $947,000
Q3 2021

Nov 15, 2021

SELL
$5.31 - $8.25 $121,583 - $188,900
-22,897 Reduced 12.74%
156,785 $914,000
Q2 2021

Aug 11, 2021

BUY
$6.81 - $9.23 $352,758 - $478,114
51,800 Added 40.51%
179,682 $1.45 Million
Q1 2021

May 17, 2021

BUY
$7.99 - $15.0 $98,692 - $185,280
12,352 Added 10.69%
127,882 $1.06 Million
Q4 2020

Feb 16, 2021

BUY
$7.04 - $11.7 $225,969 - $375,546
32,098 Added 38.47%
115,530 $876,000
Q3 2020

Nov 16, 2020

SELL
$9.98 - $18.04 $1.87 Million - $3.38 Million
-187,158 Reduced 69.17%
83,432 $889,000
Q2 2020

Aug 14, 2020

BUY
$7.49 - $15.16 $1.11 Million - $2.25 Million
148,219 Added 121.12%
270,590 $4.1 Million
Q1 2020

May 15, 2020

SELL
$4.62 - $18.74 $920,960 - $3.74 Million
-199,342 Reduced 61.96%
122,371 $1.02 Million
Q4 2019

Feb 14, 2020

BUY
$14.6 - $18.13 $817,760 - $1.02 Million
56,011 Added 21.08%
321,713 $5.44 Million
Q3 2019

Nov 14, 2019

BUY
$16.62 - $23.92 $445,748 - $641,534
26,820 Added 11.23%
265,702 $4.93 Million
Q2 2019

Aug 16, 2019

BUY
$17.79 - $22.88 $420,751 - $541,134
23,651 Added 10.99%
238,882 $5.47 Million
Q2 2019

Aug 14, 2019

BUY
$17.79 - $22.88 $3.44 Million - $4.42 Million
193,360 Added 884.09%
215,231 $4.92 Million
Q1 2019

May 15, 2019

SELL
$11.76 - $22.15 $1.76 Million - $3.31 Million
-149,574 Reduced 87.24%
21,871 $460,000
Q4 2018

Feb 14, 2019

SELL
$10.42 - $21.94 $3.12 Million - $6.56 Million
-299,149 Reduced 63.57%
171,445 $1.97 Million
Q3 2018

Nov 14, 2018

BUY
$20.4 - $24.6 $6.54 Million - $7.88 Million
320,418 Added 213.36%
470,594 $10.8 Million
Q2 2018

Aug 14, 2018

SELL
$19.02 - $24.95 $513,768 - $673,949
-27,012 Reduced 15.24%
150,176 $3.35 Million
Q1 2018

May 15, 2018

BUY
$22.55 - $29.9 $616,855 - $817,914
27,355 Added 18.26%
177,188 $4.05 Million
Q3 2017

Nov 14, 2017

BUY
$21.1 - $25.15 $3.16 Million - $3.77 Million
149,833
149,833 $3.36 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.